Literature DB >> 9168933

Bcl-2 relieves the trans-repressive function of the glucocorticoid receptor and inhibits the activation of CPP32-like cysteine proteases.

T Miyashita1, U Mami, T Inoue, J C Reed, M Yamada.   

Abstract

Glucocorticoid induces apoptosis in immature lymphocytes which is inhibitable by Bcl-2. Although glucocorticoid-mediated signal transduction is well understood, the mechanism of the induction of apoptosis by the activated glucocorticoid receptor as well as the inhibition of apoptosis by Bcl-2 remains enigmatic. Here we report that overexpressed Bcl-2 relieves the glucocorticoid receptor-mediated repressive function on the AP-1 activity and completely inhibits the activation of CPP32-like cysteine proteases. In contrast, glucocorticoid receptor-mediated transactivation was not affected by Bcl-2. This suggests that glucocorticoid may induce apoptosis by repressing transactivation by AP-1 which is relieved by Bcl-2. Furthermore, we report evidence that, in contrast with CPP32-like proteases, ICE-like proteases are not involved in this apoptotic pathway.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9168933     DOI: 10.1006/bbrc.1997.6559

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Lipopolysaccharide stimulates butyric acid-induced apoptosis in human peripheral blood mononuclear cells.

Authors:  T Kurita-Ochiai; K Fukushima; K Ochiai
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

2.  Btf, a novel death-promoting transcriptional repressor that interacts with Bcl-2-related proteins.

Authors:  G M Kasof; L Goyal; E White
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

Review 3.  The Fas/Fas ligand system and cancer: immune privilege and apoptosis.

Authors:  Vikki M Abrahams; Marijke Kamsteeg; Gil Mor
Journal:  Mol Biotechnol       Date:  2003-09       Impact factor: 2.695

4.  Microarray and pathway analysis reveals decreased CDC25A and increased CDC42 associated with slow growth of BCL2 overexpressing immortalized breast cell line.

Authors:  Jacquelyn M Long; Charles W Bell; W Samuel Fagg; Mary E Kushman; Kevin G Becker; James A McCubrey; Mary A Farwell
Journal:  Cell Cycle       Date:  2008-10-08       Impact factor: 4.534

5.  The Eosinophil Count Tends to Be Negatively Associated with Levels of Serum Glucose in Patients with Adrenal Cushing Syndrome.

Authors:  Younghak Lee; Hyon Seung Yi; Hae Ri Kim; Kyong Hye Joung; Yea Eun Kang; Ju Hee Lee; Koon Soon Kim; Hyun Jin Kim; Bon Jeong Ku; Minho Shong
Journal:  Endocrinol Metab (Seoul)       Date:  2017-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.